CD4 and systemic lupus erythematosus: LAT-1 deletion or inhibition blocks the expansion of IL-17 secreting γδ and CD4+ T cells in both human cells and imiquimod (a TLR7 agonist)-induced lupus and psoriasis-like animal models (Figure 1).